The Lancet highlights the work we do with our AMP-PD partners in enabling meaningful progress in the development of new therapies to treat Parkinson’s disease.
Philanthropy News Digest featured ASAP in this article detailing what our grantees hope to accomplish with their research.
This article from News Medical Life Sciences highlights new studies describing unprecedented details of a protein linked to genetically inherited Parkinson's disease.
ASAP is committed to making full and immediate open access a reality. The future is science without publication paywalls.
Point of view from ASAP scientific director, Randy Schekman, PhD and managing director, Ekemini A. U. Riley, PhD.